Anteris Technologies Ltd (AMEUF)
14.70
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
Anteris Technologies Enterprise Value: 241.18M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 02, 2024 | 241.18M |
May 01, 2024 | 241.18M |
April 30, 2024 | 241.18M |
April 29, 2024 | 241.18M |
April 26, 2024 | 241.18M |
April 25, 2024 | 241.18M |
April 24, 2024 | 241.18M |
April 23, 2024 | 255.99M |
April 22, 2024 | 255.99M |
April 19, 2024 | 255.99M |
April 18, 2024 | 255.99M |
April 17, 2024 | 255.99M |
April 16, 2024 | 255.99M |
April 15, 2024 | 255.99M |
April 12, 2024 | 255.99M |
April 11, 2024 | 255.99M |
April 10, 2024 | 255.99M |
April 09, 2024 | 255.99M |
April 08, 2024 | 255.99M |
April 05, 2024 | 255.99M |
April 04, 2024 | 255.99M |
April 03, 2024 | 250.10M |
April 02, 2024 | 250.10M |
April 01, 2024 | 230.31M |
March 28, 2024 | 230.31M |
Date | Value |
---|---|
March 27, 2024 | 230.31M |
March 26, 2024 | 230.31M |
March 25, 2024 | 230.31M |
March 22, 2024 | 230.31M |
March 21, 2024 | 230.31M |
March 20, 2024 | 213.19M |
March 19, 2024 | 210.87M |
March 18, 2024 | 210.87M |
March 15, 2024 | 210.87M |
March 14, 2024 | 210.87M |
March 13, 2024 | 210.87M |
March 12, 2024 | 210.87M |
March 11, 2024 | 187.60M |
March 08, 2024 | 187.60M |
March 07, 2024 | 187.60M |
March 06, 2024 | 187.60M |
March 05, 2024 | 187.60M |
March 04, 2024 | 180.64M |
March 01, 2024 | 180.64M |
February 29, 2024 | 180.64M |
February 28, 2024 | 180.64M |
February 27, 2024 | 177.88M |
February 26, 2024 | 177.88M |
February 23, 2024 | 169.32M |
February 22, 2024 | 169.32M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.043M
Minimum
Mar 02 2020
271.15M
Maximum
Jun 28 2022
114.25M
Average
86.90M
Median
Jul 08 2019
Enterprise Value Benchmarks
Alterity Therapeutics Ltd | -- |
Kazia Therapeutics Ltd | 5.265M |
Immutep Ltd | -- |
Opthea Ltd | 118.00M |
Mesoblast Ltd | -- |
Enterprise Value Related Metrics
Earnings Yield | -19.32% |
Normalized Earnings Yield | -19.32 |